Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Familial Mediterranean Fever (FMF) is a rare, inherited autoinflammatory disorder characterized by recurrent episodes of fever and painful inflammation in the abdomen, chest, or joints. Caused by mutations in the MEFV gene, it requires lifelong management—typically with colchicine—to prevent long-term complications like amyloidosis. What is Familial Mediterranean Fever and how does it affect the body? Familial Mediterranean Fever is an autoinflammatory condition, meaning it causes the body’s innate immune system to trigger "false alarms" of inflammation even when no infection is present.
TL;DR: Familial Mediterranean Fever (FMF) is a rare, inherited autoinflammatory disorder characterized by recurrent episodes of fever and painful inflammation in the abdomen, chest, or joints. Caused by mutations in the MEFV gene, it requires lifelong management—typically with colchicine—to prevent long-term complications like amyloidosis.
Familial Mediterranean Fever is an autoinflammatory condition, meaning it causes the body’s innate immune system to trigger "false alarms" of inflammation even when no infection is present. These inflammatory attacks typically last between one and three days and can be extremely painful. The inflammation primarily targets the serous membranes, which are the linings of our internal cavities, leading to peritonitis (abdominal pain), pleuritis (chest pain), and arthritis (joint pain). Over time, if the chronic inflammation is not controlled, patients are at risk of developing amyloidosis, a condition where an abnormal protein (amyloid A) builds up in vital organs, particularly the kidneys.
Familial Mediterranean Fever is most commonly found in populations originating from the Mediterranean basin, including individuals of Armenian, Turkish, Arab, Sephardic Jewish, and Greek descent. However, it can affect people of any ethnic background. The condition is genetic, and symptoms usually begin early in life; approximately 90% of patients experience their first attack before the age of 20. While both males and females are affected, some clinical studies suggest a slightly higher prevalence or more severe disease expression in males.
The underlying mechanism of Familial Mediterranean Fever involves a mutation in the MEFV gene, which provides instructions for making a protein called pyrin. Pyrin is essential for regulating the inflammatory response. When the MEFV gene is mutated, the pyrin protein does not function correctly, leading to an overactive immune response. At DiseaseMaps.org, 264 people with Familial Mediterranean Fever have joined our community, providing firsthand insight into how these genetic triggers manifest in daily life.
Distinguishing this condition from other periodic fever syndromes or rheumatologic diseases is crucial for proper management. Key clinical characteristics include:
Unlike autoimmune diseases (such as lupus or rheumatoid arthritis), where the body attacks its own tissues due to a malfunctioning adaptive immune system, Familial Mediterranean Fever is an autoinflammatory disease. This means the innate immune system—the body's first line of defense—is hyperactive. It is distinct from other periodic fever syndromes due to its specific genetic signature and its rapid, often near-total, response to colchicine therapy, which serves as both a treatment and a diagnostic indicator.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.